132 related articles for article (PubMed ID: 11108721)
41. Ets domain transcription factor PE1 suppresses human interstitial collagenase promoter activity by antagonizing protein-DNA interactions at a critical AP1 element.
Bidder M; Loewy AP; Latifi T; Newberry EP; Ferguson G; Willis DM; Towler DA
Biochemistry; 2000 Aug; 39(30):8917-28. PubMed ID: 10913304
[TBL] [Abstract][Full Text] [Related]
42. Generation of two distinct functional isoforms of dosage-sensitive sex reversal-adrenal hypoplasia congenita-critical region on the X chromosome gene 1 (DAX-1) by alternative splicing.
Hossain A; Li C; Saunders GF
Mol Endocrinol; 2004 Jun; 18(6):1428-37. PubMed ID: 15044589
[TBL] [Abstract][Full Text] [Related]
43. TEL/ETV6 is a signal transducer and activator of transcription 3 (Stat3)-induced repressor of Stat3 activity.
Schick N; Oakeley EJ; Hynes NE; Badache A
J Biol Chem; 2004 Sep; 279(37):38787-96. PubMed ID: 15229229
[TBL] [Abstract][Full Text] [Related]
44. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
Meyers S; Lenny N; Sun W; Hiebert SW
Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369
[TBL] [Abstract][Full Text] [Related]
45. Distinct functional interactions of human Skn-1 isoforms with Ese-1 during keratinocyte terminal differentiation.
Cabral A; Fischer DF; Vermeij WP; Backendorf C
J Biol Chem; 2003 May; 278(20):17792-9. PubMed ID: 12624109
[TBL] [Abstract][Full Text] [Related]
46. TEL/AML1 shows dominant-negative effects over TEL as well as AML1.
Gunji H; Waga K; Nakamura F; Maki K; Sasaki K; Nakamura Y; Mitani K
Biochem Biophys Res Commun; 2004 Sep; 322(2):623-30. PubMed ID: 15325275
[TBL] [Abstract][Full Text] [Related]
47. Characterization of NERF, a novel transcription factor related to the Ets factor ELF-1.
Oettgen P; Akbarali Y; Boltax J; Best J; Kunsch C; Libermann TA
Mol Cell Biol; 1996 Sep; 16(9):5091-106. PubMed ID: 8756667
[TBL] [Abstract][Full Text] [Related]
48. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
Huynh KD; Bardwell VJ
Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
[TBL] [Abstract][Full Text] [Related]
49. Expression of the ETS transcription factor ELF3 in the retinal pigment epithelium.
Jobling AI; Fang Z; Koleski D; Tymms MJ
Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3530-7. PubMed ID: 12407165
[TBL] [Abstract][Full Text] [Related]
50. TRIM45, a novel human RBCC/TRIM protein, inhibits transcriptional activities of ElK-1 and AP-1.
Wang Y; Li Y; Qi X; Yuan W; Ai J; Zhu C; Cao L; Yang H; Liu F; Wu X; Liu M
Biochem Biophys Res Commun; 2004 Oct; 323(1):9-16. PubMed ID: 15351693
[TBL] [Abstract][Full Text] [Related]
51. A novel modulator domain of Ets transcription factors.
Wasylyk C; Kerckaert JP; Wasylyk B
Genes Dev; 1992 Jun; 6(6):965-74. PubMed ID: 1592263
[TBL] [Abstract][Full Text] [Related]
52. TEL, a putative tumor suppressor, induces apoptosis and represses transcription of Bcl-XL.
Irvin BJ; Wood LD; Wang L; Fenrick R; Sansam CG; Packham G; Kinch M; Yang E; Hiebert SW
J Biol Chem; 2003 Nov; 278(47):46378-86. PubMed ID: 12960174
[TBL] [Abstract][Full Text] [Related]
53. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.
Golub TR; Barker GF; Lovett M; Gilliland DG
Cell; 1994 Apr; 77(2):307-16. PubMed ID: 8168137
[TBL] [Abstract][Full Text] [Related]
54. Regulation of TCF ETS-domain transcription factors by helix-loop-helix motifs.
Stinson J; Inoue T; Yates P; Clancy A; Norton JD; Sharrocks AD
Nucleic Acids Res; 2003 Aug; 31(16):4717-28. PubMed ID: 12907712
[TBL] [Abstract][Full Text] [Related]
55. Control of endothelial sprouting by a Tel-CtBP complex.
Roukens MG; Alloul-Ramdhani M; Baan B; Kobayashi K; Peterson-Maduro J; van Dam H; Schulte-Merker S; Baker DA
Nat Cell Biol; 2010 Oct; 12(10):933-42. PubMed ID: 20835243
[TBL] [Abstract][Full Text] [Related]
56. Highly conserved amino acids in Pax and Ets proteins are required for DNA binding and ternary complex assembly.
Fitzsimmons D; Lutz R; Wheat W; Chamberlin HM; Hagman J
Nucleic Acids Res; 2001 Oct; 29(20):4154-65. PubMed ID: 11600704
[TBL] [Abstract][Full Text] [Related]
57. The fusion of TEL and ABL in human acute lymphoblastic leukaemia is a rare event.
Janssen JW; Ridge SA; Papadopoulos P; Cotter F; Ludwig WD; Fonatsch C; Rieder H; Ostertag W; Bartram CR; Wiedemann LM
Br J Haematol; 1995 May; 90(1):222-4. PubMed ID: 7786792
[TBL] [Abstract][Full Text] [Related]
58. Analysis of TEL proteins in human leukemias.
Poirel H; Lacronique V; Mauchauffé M; Le Coniat M; Raffoux E; Daniel MT; Erickson P; Drabkin H; MacLeod RA; Drexler HG; Ghysdael J; Berger R; Bernard OA
Oncogene; 1998 Jun; 16(22):2895-903. PubMed ID: 9671410
[TBL] [Abstract][Full Text] [Related]
59. Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors.
Monté D; Baert JL; Defossez PA; de Launoit Y; Stéhelin D
Oncogene; 1994 May; 9(5):1397-406. PubMed ID: 8152800
[TBL] [Abstract][Full Text] [Related]
60. Genomic structure and chromosomal localization of the novel ETS factor, PE-2 (ERF).
de Castro CM; Rabe SM; Langdon SD; Fleenor DE; Slentz-Kesler K; Ahmed MN; Qumsiyeh MB; Kaufman RE
Genomics; 1997 Jun; 42(2):227-35. PubMed ID: 9192842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]